New Venous Thromboembolism Findings from Seoul National University College of Medicine Described (Incidence of venous thromboembolism in Korea from…

New Venous Thromboembolism Findings from Seoul National University College of Medicine Described (Incidence of venous thromboembolism in Korea from 2009 to 2013)

By a News Reporter-Staff News Editor at Insurance Weekly News -- Research findings on Cardiovascular Diseases and Conditions - Venous Thromboembolism are discussed in a new report. According to news reporting out of Seoul, South Korea, by VerticalNews editors, research stated, "The incidence of venous thromboembolism (VTE) is lower in Asian populations than in Western populations. The objective of the present study was to evaluate the annual age-and sex-adjusted incidence (ASR) of VTE from 2009 to 2013 in South Korea."

Our news journalists obtained a quote from the research from the Seoul National University College of Medicine, "In addition, annual change in the pattern of VTE treatment during the study period was estimated because a new direct oral anticoagulant (DOAC) had become available and was covered by health insurance in Korea beginning in January 2013. VTE cases from 2009 to 2013 were retrospectively identified based on both diagnostic and medication codes of anticoagulants used for initial treatment using the Korean Health Insurance Review and Assessment Service (HIRA) databases. The incidence of VTE increased yearly. It was significantly higher in the older population than in the younger population, and it was higher in females than in males. In 2009, ASRs of VTE, deep vein thrombosis, and pulmonary embolism were 21.3, 8.1, and 13.2 cases per 100,000 individuals, respectively in 2009. These increased to 29.2, 12.7, and 16.6 cases per 100,000, respectively, in 2013. Prescription rates of warfarin and low-molecular-weight heparin decreased with the introduction of a new anticoagulant in 2013. The proportion of subjects who underwent mechanical procedures decreased annually. The ASR of VTE in Korea continuously increased from 2009 to 2013, reflecting an increased awareness and detection of VTE as well as improved survival of patients with cancer and other morbidities."

According to the news editors, the research concluded: "Following its introduction, DOAC rapidly replaced other anticoagulants for the treatment of VTE."

For more information on this research see: Incidence of venous thromboembolism in Korea from 2009 to 2013. Plos One, 2018;13(1):e0191897. (Public Library of Science - www.plos.org; Plos One - www.plosone.org)

Our news journalists report that additional information may be obtained by contacting J. Hong, Dept. of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea. Additional authors for this research include J.H. Lee, H.Y. Yhim, W.I. Choi, S.M. Bang, H. Lee and D. Oh.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1371/journal.pone.0191897. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

Keywords for this news article include: Seoul, Hematology, South Korea, Health Insurance, Health and Medicine, Venous Thromboembolism, Embolism and Thrombosis, Cardiovascular Diseases and Conditions.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC